CAR-T specialist Kite and its partner in China are laying the foundations for the launch of its groundbreaking cancer treatment in the country. California –based Kite has set up a 50/50 joint venture ...
Gilead Sciences' Kite Pharma has become the first drugmaker to get FDA approval to use a CAR-T therapy after just one earlier systemic therapy, moving the approach up the treatment pathway. The US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results